KKR-Led Gland Pharma To Be Purchased By Fosun Pharma In $1.26 Billion Transaction

By: via Benzinga
KKR & Co. L.P. (NYSE: KKR) indicated that India-based Gland Pharma Limited signed a definitive agreement with Shanghai Fosun ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.